NFE2L2 and acute myeloid leukemia: Stable expression of the wild-type Nrf2 or dnNrf2 in U937 cells resulted in an enhanced or reduced AP-1 upregulation and activation, respectively [22], suggesting that Nrf2 may serve as an upstream regulator of AP-1 in AML cells.